Replimune Group, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
REPL Company Description
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
REPL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view REPL Smart Score
Score Breakdown
REPL Company Description
Show More
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of REPL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by REPL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on REPL's company Twitter account
WallStreetBets
Number of mentions of REPL in WallStreetBets Daily Discussion
REPL News
Recent insights relating to REPL
CNBC Recommendations
Recent picks made for REPL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in REPL
Corporate Flights
Flights by private jets registered to REPL
Our Analysis